← All diseases
Cancer
Ovarian cancer
Do you want to receive a message when there is new research about Ovarian cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence explaining what was investigated — and you will receive a message as soon as there is new research about Ovarian cancer. View what Premium costs.
Publications and studies (2868)
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Early-life body mass index and risks of breast, endometrial, and ovarian cancers: a dose-response meta-analysis of prospective studies. (2022/03/01) ♡
- In-vitro maturation and transplantation of cryopreserved ovary tissue: understanding ovarian longevity. (2022/03/01) ♡
- Peri-operative blood management of Jehovah's Witnesses undergoing cytoreductive surgery for advanced ovarian cancer. (2022/03/01) ♡
- Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells. (2022/02/14) ♡
- Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer. (2022/02/09) ♡
- A functionalized graphene oxide with improved cytocompatibility for stimuli-responsive co-delivery of curcumin and doxorubicin in cancer treatment. (2022/02/04) ♡
- Anti-proliferative cassane-type diterpenoids from the seeds of Caesalpinia minax. (2022/02/01) ♡
- Clinical indicators useful in decision-making about palliative chemotherapy for end-of-life ovarian cancer patients. (2022/02/01) ♡
- Cancer-related psychosocial factors and self-reported changes in lifestyle among gynecological cancer survivors: cross-sectional analysis of PROFILES registry data. (2022/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. P-coumaric acid alleviates cisplatin-induced ovarian toxicity in rats. (2022/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients. (2022/02/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target. (2022/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Optimization of an mHealth lifestyle intervention for families with hereditary cancer syndromes: Study protocol for a multiphase optimization strategy feasibility study. (2022/02/01) ♡
- Association between pre-diagnostic dietary pattern and survival of ovarian cancer: Evidence from a prospective cohort study. (2022/02/01) ♡
- Correction to: lncRNA ARAP1-AS1 aggravates the malignant phenotypes of ovarian cancer cells by sponging miR-4735-3p to enhance PLAGL2 expression. (2022/02/01) ♡
- Is Anti-Müllerian Hormone a Marker of Ovarian Reserve in Young Breast Cancer Patients Receiving a GnRH Analog during Chemotherapy? (2022/02/01) ♡
- [Molecular mechanism of Spatholobi Caulis in treatment of ovarian cancer based on network pharmacology and experimental verification]. (2022/02/01) ♡
- Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer. (2022/01/27) ♡
- Circular RNA CDR1As Alleviates Cisplatin-Based Chemoresistance by Suppressing miR-1299 in Ovarian Cancer. (2022/01/26) ♡
- High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note. (2022/01/26) ♡
- Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells. (2022/01/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer. (2022/01/25) ♡
- Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer. (2022/01/21) ♡
- PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma. (2022/01/20) ♡
- Total Parenteral Nutrition Treatment Improves the Nutrition Status of Gynecological Cancer Patients by Improving Serum Albumin Level. (2022/01/20) ♡
- [Bushen Huatan recipe for treatment of polycystic ovary syndrome: therapeutic mechanism based on network pharmacology and molecular docking]. (2022/01/20) ♡
- Assessing Histology Structures by Ex Vivo MR Microscopy and Exploring the Link Between MRM-derived Radiomic Features and Histopathology in Ovarian Cancer. (2022/01/19) ♡
- Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer. (2022/01/18) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In vitro cytotoxic effects of 5-Fluorouracil on isolated murine ovarian preantral follicles. (2022/01/15) ♡
- Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration. (2022/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Dietary Inflammatory Index and Ovarian Cancer Risk: A Meta-Analysis. (2022/01/01) ♡
- Docosahexaenoic Acid in the Inhibition of Tumor Cell Growth in Preclinical Models of Ovarian Cancer. (2022/01/01) ♡
- Research Status and Progress of Nutritional Support Therapy for Ovarian Cancer. (2022/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Long-Term Glucose Restriction with or without Beta-Hydroxybutyrate Enrichment Distinctively Alters Epithelial-Mesenchymal Transition-Related Signaling in Ovarian Cancer Cells. (2022/01/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort. (2022/01/01) ♡
- Sequential modulation of the WNT/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance. (2022/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Syncytiotrophoblast-derived extracellular vesicles carry apolipoprotein-E and affect lipid synthesis of liver cells in vitro. (2022/01/01) ♡
- Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression. (2022/01/01) ♡
- Unusual location of the sentinel node in the inferior gluteal region in a patient with ovarian tumor. (2022/01/01) ♡
- Drug-interaction between paclitaxel and goshajinkigan extract and its constituents. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Aromatase Enzyme in Hormone Related Diseases and Plant-Based Aromatase Inhibitors as Therapeutic Regimens. (2022/01/01) ♡
- Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis. (2022/01/01) ♡
- Juvenile granulosa cell tumor: 20 years' experience of a Tertiary Center. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer. (2021/12/31) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors. (2021/12/29) ♡
- Effect of Low-Level Laser Therapy and Sinensetin (Combination Therapy) on Tumor Cells (Hela) and Normal Cells (CHO) (2021/12/27) ♡
- Fine-tuning of the pharmacological potential of novel thiazolium ionic liquids by anion alteration. (2021/12/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer (2021/12/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence. (2021/12/17) ♡
- Early life physical activity and risk of ovarian cancer in adulthood. (2021/12/15) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.